Pharming Group N.V 20-F for FY2023
Pharming Group N.V. (PHAR)
20-F
2024-04-04
For: 2023-12-31
View Original
Added on
April 08, 2026
About this 20-F
Pharming Group N.V filed this 20-F on April 4, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $245.32M
- up 19.3% from $205.62M a year earlier
- Net loss
- $10.55M
- compared with net income of $13.67M a year earlier
- Diluted EPS
- -$0.02
- compared with $0.02 a year earlier